Ayako Yoshikawa, MD

HGCSG1901: A retrospective cohort study evaluating the safety and efficacy of S-1 and irinotecan plus bevacizumab in patients with metastatic colorectal cancer: Analysis of second-line treatment after anti-EGFR antibody

Background Although the selection of anti-EGFR antibody as first-line treatment for metastatic colorectal cancer (mCRC) patients is now decided based on primary tumor lo...

H. Okuda ;

Y. Sasaki ;

Yasuhiro Sakata ;

M. Nakamura ;

S. Yuki ;

Taisei J. Kobayashi , MD;

Y. Komatsu ;

M. Dazai ;

T. Sasaki ;

H. Nakatsumi ;

A. Sato ;

A. Ueda ;

Ayako Yoshikawa , MD;

K. Ito ;

Y. Kawamoto ;

R. Saito ;

T. Yamamura ;

M. Yagisawa ;

A. Ishiguro ;

O. Muto ;

K. Hatanaka ;

06/28/2021

Original Contribution

Comparison of In Vivo Longitudinal Strength and Conformability Following Stent Implantation in Rabbit Iliac Artery

01/29/2014

Yuji Ikari , MD, PhD, FACC, FESC;

Naoki Masuda , MD;

Nobuhiko Ogata , MD, PhD;

Gaku Nakazawa , MD;

Sho Torii , MD;

Ayako Yoshikawa , MD;

Takeshi Ijichi , MD;

Yohei Ohno , MD;

Norihiko Shinozaki , MD, PhD;

There may be a trade-off between longitudinal strength and conformability. This in vivo study investigates longitudinal strength and conformability of various stent platforms following stent implantation in rabbit iliac arteries.

There may be a trade-off between...

01/29/2014

Journal of Invasive Cardiology